Logo Image
News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademyShortsSponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Events
Webcasts
Event Calendar

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Events
  • Subscribe
  • Event Calendar
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
Clinical Operations & Strategy|
Patient Participation
Advertisement

James Sawyer, MD, CEO, Prism Ideas

Advertisement

Articles by James Sawyer, MD, CEO, Prism Ideas

The Importance of Social Media and the Internet to the Pharmaceutical Industry

ByJames Sawyer, MD, CEO, Prism Ideas
August 8th 2012
PrismFigureOne-783964-1408600784398.png

Maximizing Patient Reported Outcomes through the Internet

ByJames Sawyer, MD, CEO, Prism Ideas,Stephen Doogan
August 3rd 2012

Applied Clinical Trials

i1-776896-1408604101293.jpg

Pharmacovigilance Outsourcing: A Guide

ByJames Sawyer, MD, CEO, Prism Ideas
June 1st 2012

Applied Clinical Trials

An efficient system can be the difference between a drug being withdrawn or delivered to market.

Advertisement

Latest Updated Articles

  • PrismFigureOne-783964-1408600784398.png
    Maximizing Patient Reported Outcomes through the Internet

    August 3rd 2012

  • The Importance of Social Media and the Internet to the Pharmaceutical Industry
    The Importance of Social Media and the Internet to the Pharmaceutical Industry

    August 8th 2012

  • i1-776896-1408604101293.jpg
    Pharmacovigilance Outsourcing: A Guide

    June 1st 2012



Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy

2

ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion

3

Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial

4

Bringing the Voice of Clinical Practice and Patients into Drug Development

5

ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us